The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Treating advanced prostate cancer
2.
For treatment, the majority of cancer patients choose complementary therapies.
3.
Study opens up possibility of bespoke prostate cancer treatment
4.
In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.
5.
Telehealth in the pandemic era resulted in fewer therapy interruptions.
1.
CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies
2.
Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion
3.
Understanding Sideroblastic Anemia and its Symptoms
4.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
5.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
2.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation